Description: This research examines the intersection of US insurance ratemaking and analytics techniques in advanced modern rating systems and associated regulatory considerations in the US.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: The Regulation and Taxation e-course covers the regulatory environment of life and annuity insurance in the U.S. and Canada, with an emphasis on actuaries.

Description: It comes as no surprise that there has been a great deal of activity by regulators in trying to understand the evolution of UW and the use of data. CO, WA, DC, CA, and on and on. But, where are we now? What is the latest activity? What are the technical issues that need to be considered? What testing protocols should carriers be preparing? How do you know what to look for with respect to fairness concerns? How do you prepare your company to test and if necessary defend your data practices? Join this panel discussion, where they will bring varying perspectives from some of the industry's leading voices on this topic.

Description: The American Academy of Actuaries Health Solvency Subcommittee and the NAIC Health Risk-Based Capital (E) Working Group are in the process of analyzing and reviewing the H2-Underwriting Risk component and the managed care credit calculation in the health risk-based capital (HRBC) formula. Come learn what changes are ahead! While RBC is designed for solvency issues, also come hear about other ways health insurers manage their capital and surplus levels. Are others doing something you should try?

Description: The world of climate risk disclosures has seen dizzying levels of change in the last few years. In 2023, many regulators have publicly issued guidance on what insurance companies and other FIs should look to disclose. So what are we seeing in these disclosures and how do we use this information? Join our panel of experts to learn about the evolution of U.S. life insurance industry's climate disclosures and how insurers of all sizes and complexities are responding to NAIC's requirements.

Description: Come hear from a panel focused on hot topics in the life/LTC combination product market. The presenters will look at regulatory developments, evolution of the risk selection process, and provide an update to the assumption of natural risk hedging in hybrid products.

Description: Attend this webcast to learn more on how to navigate managing ESG principles in the new normal of a post-COVID world. Enhance your ESG insights in a post-pandemic landscape.

Description: Join us for an insightful webcast as we delve into the far-reaching implications of the recent Supreme Court decision to overturn Chevron deference. This landmark ruling, which previously granted federal agencies significant leeway in interpreting ambiguous statutes, is set to reshape the landscape of healthcare policy.

Description: How are regulation and innovation intertwined? How to regulate artificial intelligence/machine learning in the insurance industry? We will cover how regulators are striking the balance between protection of their constituents and supporting innovation. We will zoom into the case of predictive analytics and the regulatory attempt at avoiding undue discrimination. Let's discuss what this really mean.